0001790190-19-000001.txt : 20191008 0001790190-19-000001.hdr.sgml : 20191008 20191007181916 ACCESSION NUMBER: 0001790190-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191008 DATE AS OF CHANGE: 20191007 EFFECTIVENESS DATE: 20191008 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHAMISHI THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001790190 IRS NUMBER: 322669722 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350542 FILM NUMBER: 191141614 BUSINESS ADDRESS: STREET 1: 711 DIMMEYDALE DRIVE CITY: DEERFIELD STATE: IL ZIP: 60015 BUSINESS PHONE: 630-336-3541 MAIL ADDRESS: STREET 1: 711 DIMMEYDALE DRIVE CITY: DEERFIELD STATE: IL ZIP: 60015 D 1 primary_doc.xml X0708 D LIVE 0001790190 CHAMISHI THERAPEUTICS, INC. 711 DIMMEYDALE DRIVE DEERFIELD IL ILLINOIS 60015 630-336-3541 DELAWARE None None Corporation true 2019 James Sullivan c/o Chamishi Therapeutics, Inc. 711 Dimmeydale Dr. Deerfield IL ILLINOIS 60015 Executive Officer Director Chief Executive Officer and Director Steven Squinto 920 Park Ave. New York NY NEW YORK 10028 Executive Officer Director President and Director Other Technology Decline to Disclose 06b false 2019-09-20 false true true Series Seed Preferred Stock false 0 1153850 490386 663464 Total Remaining to be Sold includes issuer's good faith valuation of $288,462 of certain non-cash consideration that may be exchanged for securities in the future. false 2 0 0 0 false CHAMISHI THERAPEUTICS, INC. /s/ James Sullivan James Sullivan Chief Executive Officer 2019-10-07